• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Topics Engaged In

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 19
12:00 pm - 1:00 pm CST

Les Turner ALS Foundation Webinar: The Caregiver’s Journey

Nov 20
7:45 am - 5:15 pm MST

Canadian Society of Palliative Medicine: Palliative Horizons – Clinical Approaches to ALS and Parkinson’s

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

Dec 5
December 5 - December 6

Alliance Meeting

Dec 7
December 7 - December 8

Allied Professionals Forum

View Calendar

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Willi Klein, UK

    Willi Klein, UK

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Ali Var, Turkey

    Ali Var, Turkey

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Phil Rossall, UK

    Phil Rossall, UK

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • David Watson, Scotland

    David Watson, Scotland

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Animesh Kumar, India

    Animesh Kumar, India

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Ian Gale, Australia

    Ian Gale, Australia

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Rob Tison, USA

    Rob Tison, USA

  • David Solomon, UK

    David Solomon, UK

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • Daniela Maria Daverio, Argentina

    Daniela Maria Daverio, Argentina

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Jack Buzby, USA

    Jack Buzby, USA

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • David Bishop, UK

    David Bishop, UK

  • Mike Cels, Canada

    Mike Cels, Canada

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • JP

    JP

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login